Showing results (2041-2050 of 2,559) with videos related to

Sort By:
Pageof 256
Carcinogenesis|May 1, 1992
Comparison of Ki-ras gene mutation among simultaneously occurring multiple urethan-induced lung tumors in individual miceH Ohmori, T Abe, H Hirano, et al.
[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai|October 1, 1990
[Tricuspid annuloplasty--modified technique]M Tanaka, E Takeuchi, T Watanabe, et al.
[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai|January 1, 1991
[The significance of internal thoracic artery-left anterior descending coronary artery bypass grafting in postoperative angiographic studies--with reference to indication of ITA and factors of string sign]K Yasuura, H Okamoto, A Matsuura, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|July 1, 1992
[Problems and prevention in using arterial grafts for coronary artery bypass grafting]K Yasuura, A Matsuura, T Maseki, et al.
[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai|September 1, 1992
[Analysis of the determinant factors for open heart surgery without blood transfusion by the quantification theory--possibility of application of maximum surgical blood order schedule for open heart surgery]T Sakurada, R Kuribayashi, H Aida, et al.
The Japanese Journal of Antibiotics|January 1, 1994
[Pharmacokinetic and clinical studies with cefozopran in the pediatric field. Pediatric Study Group of Cefozopran]R Fujii, T Abe, T Tajima, et al.
Vox Sanguinis|November 3, 2005
Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donorsH Suzuya, T Watanabe, R Nakagawa, et al.
Scientific Reports|September 26, 2018
Lath formation mechanisms and twinning as lath martensite substructures in an ultra low-carbon iron alloyD H Ping, S Q Guo, M Imura, et al.
The Japanese Journal of Antibiotics|November 1, 1988
[A clinical trial of astromicin, a new aminoglycoside antibiotic, in thoracotomized patients and astromicin concentrations in the lung tissue]M Imaizumi, T Niimi, Y Uchida, et al.
Cancer|April 1, 1991
Effectiveness of high-dose MCNU therapy and hematopoietic stem cell autografts treatment of childhood acute leukemia/lymphoma with high-risk featuresY Takaue, T Watanabe, Y Hoshi, et al.
Pageof 256